Novavax Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
06/23

DJ Novavax Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ slid 1.42% to $9.00 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.29% to 51,712.71 and the NASDAQ Composite Index falling 1.32% to 26,166.60.

This was the stock's second consecutive day of losses.

Novavax Inc. closed 24.81% short of its 52-week high of $11.97, which the company reached on February 26th.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.27% to $231.29, Pfizer Inc. $(PFE)$ fell 0.52% to $25.08, and Merck & Co. Inc. $(MRK)$ rose 1.41% to $115.48.

Trading volume (3.7 M) remained 1.2 million below its 50-day average volume of 4.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 22, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 22, 2026 17:28 ET (21:28 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10